Search filters

List of works by Gary Middleton

A pilot study of MVP (mitomycin-C, vinblastine and cisplatin) chemotherapy in small-cell lung cancer

scientific article published on June 1, 1998

An immunogenomic stratification of colorectal cancer: Implications for development of targeted immunotherapy

scientific article

Are we ready to start studies of Th17 cell manipulation as a therapy for cancer?

scientific article published on November 16, 2011

BRAF-mutant Transcriptional Subtypes Predict Outcome of Combined BRAF, MEK, and EGFR Blockade with Dabrafenib, Trametinib, and Panitumumab in Patients with Colorectal Cancer

scientific article published on 11 February 2020

Bevacizumab (Avastin)

article published in 2004

Challenges in molecular testing in non-small-cell lung cancer patients with advanced disease

scientific article published on September 2016

Clinical benefit from palliative chemotherapy in non-small-cell lung cancer extends to the elderly and those with poor prognostic factors

scientific article published on July 1, 1998

Combined BRAF, EGFR, and MEK Inhibition in Patients with BRAFV600E-Mutant Colorectal Cancer

scientific article published on 5 February 2018

Corrigendum: Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution

scientific article published in Nature

Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial

scientific article

Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13

scientific article published on June 5, 2011

Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial

scientific article published on 19 June 2014

Good symptom relief with palliative MVP (mitomycin-C, vinblastine and cisplatin) chemotherapy in malignant mesothelioma

scientific article published on March 1, 1998

Immunobiological effects of gemcitabine and capecitabine combination chemotherapy in advanced pancreatic ductal adenocarcinoma

scientific article published on 4 February 2016

Investigating the poor outcomes of BRAF-mutant advanced colorectal cancer: analysis from 2530 patients in randomised clinical trials

scientific article published on 19 December 2016

Multicenter, Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Pravastatin Added to First-Line Standard Chemotherapy in Small-Cell Lung Cancer (LUNGSTAR).

scientific article published on 27 February 2017

New treatment options for advanced pancreatic cancer

scientific article published on October 2008

Phase II, open-label trial to assess QTcF effects, pharmacokinetics and antitumor activity of afatinib in patients with relapsed or refractory solid tumors

scientific article published on 2 October 2013

Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution

scientific article

Publisher Correction: The National Lung Matrix Trial of personalized therapy in lung cancer

scientific article published on 05 September 2020

T1-weighted magnetic resonance imaging in breast cancer vertebral metastases: Changes on treatment and correlation with response to therapy

scientific article published on 01 July 1998

The National Lung Matrix Trial of personalized therapy in lung cancer

scientific article published on 15 July 2020

The National Lung Matrix Trial: translating the biology of stratification in advanced non-small-cell lung cancer

scientific article

The role of B lymphocytes in the immuno-biology of non-small-cell lung cancer

scientific article published on 04 January 2020

Time to adjuvant chemotherapy following colorectal cancer resection is associated with an improved survival

scientific article published on May 2014

Tracking genomic cancer evolution for precision medicine: the lung TRACERx study

scientific article

Tracking the Evolution of Non-Small-Cell Lung Cancer

scientific article published on 26 April 2017

Vandetanib plus gemcitabine versus placebo plus gemcitabine in locally advanced or metastatic pancreatic carcinoma (ViP): a prospective, randomised, double-blind, multicentre phase 2 trial.

scientific article